Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors Koichiro OotsuKazunori GotohTakashi Houkan Original articles Pages: 71 - 80
Intravesical treatment of bladder cancer with recombinant human interferon-β Tadao NiijimaTakashi UmedaToyofumi Ueda Original articles Pages: 81 - 85
Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity Paulette M. Furbert-HarrisCharles H. Evans Original articles Pages: 86 - 91
Relative positions of some epitopes on carcinoembryonic antigen Åke LarssonRahul GhoshSten Hammarström Original articles Pages: 92 - 96
Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin Fujio SuzukiRichard B. PollardHiroshi Maeda Original articles Pages: 97 - 104
Rat serum antibodies binding to high-molecular-weight glycoprotein(s) on syngeneic colon carcinomas, demonstrated by competition with rat monoclonal antibody Bo JanssonThomas BrodinHans Olov Sjögren Original articles Pages: 105 - 112
Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: Immunosuppression, immunogenicity, and relation to immunosuppressive tumor products Margaret NelsonDavid S. NelsonRalph Snyderman Original articles Pages: 113 - 118
THF-γ2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma Rachel OphirMarit PechtNathan Trainin Original articles Pages: 119 - 125
Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer Kazumi FurukawaEva LotzováJ. Taylor Wharton Original articles Pages: 126 - 132
